Published in Am J Gastroenterol on July 01, 1999
Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43
Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol (2011) 1.98
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.42
Rescue Therapy for Helicobacter pylori Infection 2012. Gastroenterol Res Pract (2012) 1.10
Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium. J Clin Microbiol (2011) 1.00
"Rescue" regimens after Helicobacter pylori treatment failure. World J Gastroenterol (2008) 0.99
Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance. Infect Immun (2010) 0.98
Molecular testing for antibiotic resistance in Helicobacter pylori. Gut (2002) 0.92
Causes of failure of eradication of Helicobacter pylori. BMJ (2002) 0.91
Second-line rescue therapy of helicobacter pylori infection. Therap Adv Gastroenterol (2009) 0.89
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China. Eur J Gastroenterol Hepatol (2013) 0.88
Age-dependent eradication of Helicobacter pylori in Japanese patients. World J Gastroenterol (2010) 0.88
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly. Gastroenterol Clin North Am (2015) 0.87
Helicobacter pylori eradication in West Asia: a review. World J Gastroenterol (2014) 0.86
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial. J Korean Med Sci (2011) 0.86
Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned? J Clin Microbiol (2014) 0.85
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. World J Gastroenterol (2008) 0.84
First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective. World J Gastroenterol (2010) 0.84
Diagnostic methods for Helicobacter pylori detection and eradication. Br J Clin Pharmacol (2003) 0.81
Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure. Dig Dis Sci (2006) 0.80
A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgrad Med J (2002) 0.78
Adhesion and Invasion of Gastric Mucosa Epithelial Cells by Helicobacter pylori. Front Cell Infect Microbiol (2016) 0.75
Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens. World J Gastrointest Pharmacol Ther (2015) 0.75
Re: Van der Wouden et al.: the influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens. Am J Gastroenterol (2000) 0.75
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays. Aliment Pharmacol Ther (2012) 3.59
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology (1996) 3.54
The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther (1995) 2.74
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol (2001) 2.71
Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol (1996) 2.65
Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med (1994) 2.62
Is surveillance of the small bowel indicated for Lynch syndrome families? Gut (2007) 2.42
Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet (1999) 2.27
Stable amoxicillin resistance in Helicobacter pylori. Lancet (1998) 2.20
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet (1990) 2.12
Use of PCR with feces for detection of Helicobacter pylori infections in patients. J Clin Microbiol (1994) 2.09
Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes (1976) 2.04
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol (2000) 1.89
Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology (2001) 1.84
Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res (1999) 1.79
Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis (2004) 1.77
Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples. J Clin Microbiol (1993) 1.62
No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J (1998) 1.60
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet (2002) 1.57
Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut (2003) 1.55
Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet (1984) 1.53
Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients. Clin Endocrinol (Oxf) (2000) 1.53
Glucose concentration in subcutaneous extracellular space. Diabetes Care (1993) 1.53
Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. BJOG (2001) 1.50
Evaluation of clinical and home performance of the 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol (1995) 1.45
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther (2006) 1.44
The accuracy of the Helicobacter pylori stool antigen test in diagnosing H. pylori in treated and untreated patients. Eur J Gastroenterol Hepatol (2001) 1.43
Microscopic colitis: an unfamiliar but treatable disease. Neth J Med (2009) 1.43
Evaluation of a cytological scoring system for predicting histological grade and disease-free survival in primary breast cancer. Cytopathology (1994) 1.42
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology (1993) 1.41
Noninvasive metabolic assessment of human donor livers: prognostic value of 31P-magnetic resonance spectroscopy for early graft function. Transplantation (1997) 1.40
The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol (2001) 1.40
Erythrocyte Na+/Li+ countertransport and Na+/K+-2Cl- co-transport measurement in essential hypertension: useful diagnostic tools or failure? A meta-analysis of 17 years of literature. Clin Sci (Lond) (1998) 1.39
[ACE-inhibitors increase the risk of hypoglycemia in diabetics]. Ned Tijdschr Geneeskd (1996) 1.39
Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet (2003) 1.38
Cost effectiveness of a new strategy to identify HNPCC patients. Gut (2005) 1.38
Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut (2002) 1.38
One year outcome in mild to moderate head injury: the predictive value of acute injury characteristics related to complaints and return to work. J Neurol Neurosurg Psychiatry (1999) 1.37
The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer (1996) 1.35
Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther (1999) 1.34
Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol (1997) 1.34
Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia (2009) 1.32
A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med (1977) 1.29
Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant (2006) 1.26
Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur J Clin Microbiol Infect Dis (1996) 1.26
Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects. Clin Microbiol Infect (2010) 1.25
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol (1998) 1.24
Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer (2010) 1.24
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther (2006) 1.22
Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut (1999) 1.18
Familial testicular cancer in a single-centre population. Eur J Cancer (1999) 1.17
Primary renal graft thrombosis. Nephrol Dial Transplant (1996) 1.16
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant (1995) 1.15
Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care (1984) 1.15
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res (1992) 1.14
Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands. Emerg Infect Dis (1997) 1.12
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer (2005) 1.12
A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet (2001) 1.11
Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens. Clin Microbiol Infect (2011) 1.11
Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. Hum Pathol (2002) 1.11
Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology (1998) 1.11
Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. J Clin Oncol (1995) 1.10
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer (1983) 1.09
Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut (1994) 1.09
Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology (1984) 1.08
Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Crit Rev Oncol Hematol (2003) 1.08
In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother (1994) 1.08
Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.07
Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients. Transpl Int (1996) 1.07
Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes (1976) 1.06
Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. Clin Microbiol Infect (2008) 1.06
Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res (1996) 1.05
Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol (1998) 1.05
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer (1995) 1.04
Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med (2005) 1.04
Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. Carcinogenesis (2000) 1.03
The diagnostic value of 124I-PET in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2008) 1.02
Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest (1994) 1.02
Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse. Arthritis Rheum (1999) 1.02
Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori. J Clin Microbiol (1997) 1.02
Computed tomography and magnetic resonance imaging in mild to moderate head injury: early and late imaging related to outcome. Ann Neurol (1999) 1.01
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. Am J Gastroenterol (1998) 1.00
Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother (1995) 1.00